Coccidiosis Vaccines Market Size & Share Analysis 2032: Key Trends According to a newly published market research report by 24LifeSciences, global Coccidiosis Vaccines market was valued at USD 147 million in 2023 and is projected to reach USD 209 million by 2030, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. Coccidiosis vaccines are biological preparations designed to prevent coccidiosis, a parasitic disease caused by various species of the protozoan genus Eimeria. These vaccines typically contain live attenuated or inactivated forms of Eimeria parasites that stimulate the host's immune system to develop protective immunity. The shift towards vaccination is accelerated by growing concerns over antimicrobial resistance and increasing consumer demand for antibiotic-free animal products. This strategic transition from chemical treatments represents a fundamental shift in sustainable animal health management across global farming operations. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3921/coccidiosis-vaccines--global-outlook-and-market

Rising Demand for Animal Healthcare Boosting the Veterinary Hypodermic Needles Market at a CAGR of 7.4% According to a new report from Intel Market Research, the global Veterinary Hypodermic Needles market was valued at USD 109 million in 2025 and is projected to reach USD 179 million by 2034, growing at a CAGR of 7.4% during the forecast period (2025-2034). 📥 Download Sample Report: https://www.intelmarketresearch.com/download-free-sample/36575/veterinary-hypodermic-needles-market 🌐 Website: https://www.intelmarketresearch.com 📞 Asia-Pacific: +91 9169164321 🔗 LinkedIn: Follow Us